Evidence map›Paper›PMID 38751007›Full record

ArticleAging cell2024

Circulating microRNA profile of long-lived Okinawans identifies novel potential targets for optimizing lifespan and health span.

Sarah Noureddine, Augusto Schneider, Sydney Strader, Xiang Zhu, Joseph Dhahbi, Richard Allsopp, D Craig Willcox, Timothy A Donlon, Michio Shimabukuro, Moritake Higa and 6 more

Abstract read
In one paragraph

Article in Aging cell, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Sarah NoureddineUniversity of Central Florida College of Medicine, Burnett School of Biomedical Sciences, Orlando, Florida, USA.ORCID 0000-0002-7582-5985
Augusto SchneiderFaculdade de Nutrição, Universidade Federal de Pelotas, Pelotas, Brazil.
Sydney StraderUniversity of Central Florida College of Medicine, Burnett School of Biomedical Sciences, Orlando, Florida, USA.
Xiang ZhuUniversity of Central Florida College of Medicine, Burnett School of Biomedical Sciences, Orlando, Florida, USA.
Joseph DhahbiDepartment of Medical Education, School of Medicine, California University of Science & Medicine, Colton, California, USA.
Richard AllsoppInstitute for Biogenesis Research, John A. Burns School of Medicine, University of Hawai'i, Honolulu, Hawaii, USA.
D Craig WillcoxCenter of Biomedical Research Excellence for Translational Research on Aging, Kuakini Medical Center, Honolulu, Hawaii, USA.
Timothy A DonlonCenter of Biomedical Research Excellence for Translational Research on Aging, Kuakini Medical Center, Honolulu, Hawaii, USA.
Michio ShimabukuroOkinawa Research Center for Longevity Science, Urasoe, Japan.
Moritake HigaDiabetes and Life-Style Related Disease Center, Tomishiro Central Hospital, Tomishiro, Japan.
Makoto SuzukiOkinawa Research Center for Longevity Science, Urasoe, Japan.
Trevor TorigoeInstitute for Biogenesis Research, John A. Burns School of Medicine, University of Hawai'i, Honolulu, Hawaii, USA.
Sarah AshiquealiUniversity of Central Florida College of Medicine, Burnett School of Biomedical Sciences, Orlando, Florida, USA.ORCID 0000-0003-1980-1054
Hariom YadavUSF Center for Microbiome Research, Microbiomes Institute, University of South Florida Morsani College of Medicine, Tampa, Florida, USA.ORCID 0000-0003-4504-1597
Bradley J WillcoxCenter of Biomedical Research Excellence for Translational Research on Aging, Kuakini Medical Center, Honolulu, Hawaii, USA.
Michal M MasternakUniversity of Central Florida College of Medicine, Burnett School of Biomedical Sciences, Orlando, Florida, USA.ORCID 0000-0002-8483-930X

Funding

Productive and Leisure Activities and Cognition in Later LifeP20GM125526 · NIGMS · KUAKINI MEDICAL CENTER · PI LEE, YEONJUNG · 2019 to 2023
$12.0M
FOXO3 Genotype, InflammAging, Cardiovascular Disease, and Dementia. Kuakini Hawaii Lifespan Study III. Administrative Supplement.R01AG027060 · NIA · KUAKINI MEDICAL CENTER · PI Gregory J. Tranah, BRADLEY JOHN WILLCOX · 2005 to 2026
$8.1M
Repurposing of Metormin for Older Patients with HFpEFU01AG076928 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI KITZMAN, DALANE W, YADAV, HARIOM · 2022 to 2024
$2.3M
Gut microbiota-based biomarkers of Alzheimer's disease and its modulation by a ketogenic dietR56AG064075 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI YADAV, HARIOM · 2020 to 2021
$1.2M
Microbial therapy improves gut permeability to reduce cognitive decline and Alzheimer’s diseaseRF1AG071762 · NIA · UNIVERSITY OF SOUTH FLORIDA · PI YADAV, HARIOM · 2021 to 2021
$1.1M
The role of gut microbiota in the efficacy of ketogenic diet to ameliorate Alzheimer's diseaseR21AG072379 · NIA · UNIVERSITY OF SOUTH FLORIDA · PI YADAV, HARIOM · 2021 to 2021
$429k
Identification of bacterial strains for development of an oral probiotic aimed at increasing nitric oxide bioavailabilityR21DE032197 · NIDCR · WAKE FOREST UNIVERSITY · PI KIM-SHAPIRO, DANIEL B, YADAV, HARIOM · 2023 to 2024
$422k
Metformin and Alzheimer's disease: Underlying Mechanisms that Ameliorate ProgressionR56AG069676 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI YADAV, HARIOM · 2020 to 2020
$388k
Ovarian derived exosomal miRNA as a juvenile protective factorsR56AG074499 · NIA · UNIVERSITY OF CENTRAL FLORIDA · PI MASTERNAK, MICHAL MATEUSZ · 2022 to 2022
$287k
Florida Department of Health 22A17National Science Foundation 2317758NIA NIH HHS R01 AG027060NIA NIH HHS R21 AG072379NIA NIH HHS R56 AG064075NIA NIH HHS R56 AG069676NIA NIH HHS R56 AG074499NIA NIH HHS R56AG074499NIA NIH HHS RF1 AG071762NIA NIH HHS U01 AG076928NIDCR NIH HHS R21 DE032197NIGMS NIH HHS P20 GM125526NIH HHS 1P20GM125526NIH HHS 5R01AG027060NIH HHS R21AG072379NIH HHS R21DE032197NIH HHS R56AG064075NIH HHS R56AG069676NIH HHS RF1AG071762NIH HHS U01AG076928Okinawan Research Center for Longevity ScienceU.S. Department of Defense W81XWH-18-PRARP AZ180098
6 · The paper itself

Abstract

Nonagenarians and centenarians serve as successful examples of aging and extended longevity, showcasing robust regulation of biological mechanisms and homeostasis. Given that human longevity is a complex field of study that navigates molecular and biological mechanisms influencing aging, we hypothesized that microRNAs, a class of small noncoding RNAs implicated in regulating gene expression at the post-transcriptional level, are differentially regulated in the circulatory system of young, middle-aged, and nonagenarian individuals. We sequenced circulating microRNAs in Okinawan males and females <40, 50-80, and >90 years of age accounting for FOXO3 genetic variations of single nucleotide polymorphism (SNP) rs2802292 (TT - common vs. GT - longevity) and validated the findings through RT-qPCR. We report five microRNAs exclusively upregulated in both male and female nonagenarians with the longevity genotype, play predictive functional roles in TGF-β, FoxO, AMPK, Pi3K-Akt, and MAPK signaling pathways. Our findings suggest that these microRNAs upregulated in nonagenarians may provide novel insight into enhanced lifespan and health span. This discovery warrants further exploration into their roles in human aging and longevity.

Indexed as

LongevityAdultAgedAged, 80 and overAgingCirculating MicroRNAFemaleHumansJapanMaleMicroRNAsMiddle AgedPolymorphism, Single NucleotideCirculating MicroRNAMicroRNAsagingFOXO3longevitymicroRNAsOkinawan nonagenarians

Identifiers

PMID38751007
PMCPMC11320357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.